Labeling
Both the actual content of Fosphenytoin Sodium and the content of Phenytoin Sodium,expressed in terms of phenytoin sodium equivalents,are stated prominently on the label.
(Official February 1,2006)
Identification
A:Infrared Absorption á197Kñ
Test specimen
Transfer a 5-mLaliquot of Injection to a 100-mLbeaker,add 30mLof acetone to form a white precipitate,and stir for 20minutes using a magnetic stirrer.Filter in vacuum,and collect the precipitate using suitable filter paper.Allow to dry in vacuum for 15minutes.
B:
The retention time of the major peak in the chromatogram of the Assay preparationcorresponds to that in the chromatogram of the Standard preparation,as obtained in the Assay.
Related compounds
Buffer solution,Mobile phase,Standard stock solution 1,Standard stock solution 2,and Chromatographic system
Proceed as directed in theAssay.
Standard solution
Use theStandard preparation,prepared as directed in theAssay.
Test solution
Use theAssay preparation,prepared as directed in theAssay.
Procedure
Inject a volume (about 40µL)of the
Standard solution and the
Test solution into the chromatograph,record the chromatograms,and measure the peak areas.Calculate the percentages of phenytoin,phenytoin related compound A,phenytoin related compound B,and unknown impurities in each mLof Injection taken by the formula:
200,000(C/VL)(ri/rS),
in which
Cis the concentration,in mg per mL,of the respective impurity in the
Standard solution;Vis the volume,in mL,of the Injection taken to prepare the
Test solution;Lis the labeled amount,in mg per mL,of fosphenytoin sodium in the Injection;and
riand
rSare the individual peak responses of the impurities in the chromatograms obtained from the
Test solution and the
Standard solution,respectively:not more than 1.5%of phenytoin related compound Bis found;not more than 0.2%of phenytoin is found;not more than 0.2%of phenytoin related compound Ais found;not more than 0.1%of any individual unknown impurity is found;and not more than 2.0%total impurities is found.
[NOTEUse the peak area and concentration of the
USP Phenytoin RSin the
Standard solution as
rSand
C,respectively,to calculate the percentage of the unknown impurities.
]
Assay
Buffer solution
Dissolve about 8.2g of monobasic potassium phosphate in 1Lof water.Adjust with 6Npotassium hydroxide solution to a pHof 6.5±0.05.
Mobile phase
Prepare a filtered and degassed mixture of
Buffer solution,methanol,and acetonitrile (73:25:2).Make adjustments if necessary (see
System Suitability under
Chromatography á621ñ).
Standard stock solution 1
Dissolve an accurately weighed quantity of
USP Fosphenytoin Sodium RSin methanol,and dilute quantitatively,and stepwise if necessary,with
Buffer solution to obtain a solution having a known concentration of about 0.75mg per mL.
Standard stock solution 2
Dissolve an accurately weighed quantity of
USP Phenytoin RS,USP Phenytoin Related Compound A RS,and
USP Phenytoin Related Compound B RSin methanol,and dilute quantitatively,and stepwise if necessary,with methanol to obtain a solution having a known concentration of about 0.0075mg per mL,0.0075mg per mL,and 0.015mg per mL,respectively.
Standard preparation
Transfer 10.0mLofStandard stock solution 1and 5.0mLofStandard stock solution 2to a 50-mLvolumetric flask.Dilute withBuffer solution to volume,and mix.
Assay preparation
Transfer an accurately measured volume of the Injection,equivalent to about 300mg of fosphenytoin,to a 200-mLvolumetric flask,dilute with methanol to volume,and mix.Transfer 5.0mLof this solution to a 50-mLvolumetric flask.Dilute withBuffer solution to volume,and mix.
Chromatographic system(see Chromatography á621ñ)
The liquid chromatograph is equipped with a 214-nm detector and a 4.6-mm ×15-cm column that contains packing L11.The flow rate is about 1.25mLper minute.Chromatograph the
Standard preparation,and record the peak responses as directed for
Procedure:the relative retention times are about 0.3for phenytoin related compound B,about 0.5for phenytoin related compound A,1.0for fosphenytoin,and about 3.8for phenytoin;the resolution,
R,between phenytoin related compound Band phenytoin related compound Ais not less than 4.0;the column efficiency is not less than 2250theoretical plates for the fosphenytoin peak;the tailing factor is not more than 1.8for the fosphenytoin peak;and the relative standard deviation for replicate injections is not more than 1.0%for the fosphenytoin peak and not more than 5.0%for the phenytoin related compound B,phenytoin related compound A,and phenytoin peaks.
Procedure
Separately inject equal volumes (about 40µL)of the
Standard preparation and the
Assay preparation into the chromatograph,record the chromatograms,and measure the peak areas for fosphenytoin.Calculate the quantity,in mg,of fosphenytoin sodium (C
16H
13N
2Na
2O
6P)in each mLof the Injection taken by the formula:
2000(C/V)(rU/rS),
in which
Cis the concentration,in mg per mL,of
USP Fosphenytoin Sodium RSin the
Standard preparation;Vis the volume,in mL,of the Injection taken to prepare the
Assay preparation;and
rUand
rSare the fosphenytoin peak areas obtained from the
Assay preparation and the
Standard preparation,respectively.